Back to Search
Start Over
Association Between Genetic Testing for Hereditary Breast Cancer and Contralateral Prophylactic Mastectomy Among Multiethnic Women Diagnosed With Early-Stage Breast Cancer
- Source :
- JCO Oncol Pract
- Publication Year :
- 2022
- Publisher :
- American Society of Clinical Oncology (ASCO), 2022.
-
Abstract
- PURPOSE: Increasing usage of multigene panel testing has identified more patients with pathogenic or likely pathogenic (P or LP) variants in low-moderate penetrance genes or variants of uncertain significance (VUS). Our study evaluates the association between genetic test results and contralateral prophylactic mastectomy (CPM) among patients with breast cancer. METHODS: We conducted a retrospective cohort study among women diagnosed with unilateral stage 0-III breast cancer between 2013 and 2020 who underwent genetic testing. We examined whether genetic test results were associated with CPM using multivariable logistic regression models. RESULTS: Among 707 racially or ethnically diverse women, most had benign or likely benign (B or LB) variants, whereas 12.5% had P or LP and 17.9% had VUS. Racial or ethnic minorities were twice as likely to receive VUS. Patients with P or LP variants had higher CPM rates than VUS or B or LB (64.8% v 25.8% v 25.9%), and highest among women with P or LP variants in high-penetrance genes (74.6%). On multivariable analysis, P or LP compared with B or LB variants were significantly associated with CPM (odds ratio = 4.24; 95% CI, 2.48 to 7.26). CONCLUSION: Women with P or LP variants on genetic testing were over four times more likely to undergo CPM than B or LB. Those with VUS had similar CPM rates as B or LB. Our findings suggest appropriate genetic counseling and communication of cancer risk to multiethnic breast cancer survivors.
- Subjects :
- Oncology
medicine.medical_specialty
Breast Neoplasms
ORIGINAL CONTRIBUTIONS
Contralateral Prophylactic Mastectomy
Breast cancer
Internal medicine
medicine
Humans
Genetic Testing
Stage (cooking)
Mastectomy
Likely pathogenic
Retrospective Studies
Genetic testing
medicine.diagnostic_test
Oncology (nursing)
business.industry
Health Policy
medicine.disease
Penetrance
Prophylactic Mastectomy
Female
business
Hereditary Breast Cancer
Subjects
Details
- ISSN :
- 26881535 and 26881527
- Volume :
- 18
- Database :
- OpenAIRE
- Journal :
- JCO Oncology Practice
- Accession number :
- edsair.doi.dedup.....008ffb34b1bd39308b321d371d3e8bcf